期刊文献+

超声造影定量指标在鉴别子宫内膜增生不同病理分型中的应用价值 被引量:5

The value of quantitative parameters of contrast-enhanced ultrasound in evaluation of different pathological types of endometrial hyperplasia
原文传递
导出
摘要 目的探讨超声造影在子宫内膜增生不同病理分型定量评估中的应用价值。方法选择2016年1~10月在南京中医药大学附属医院妇科拟诊为子宫内膜增生(endometrial hyperplasia,EH)的病例50例,在行诊断性刮宫前行子宫内膜超声造影检查,获取时间-强度曲线(time-intensity curve,TIC),分别采集峰值强度(peak time,PI)、平均渡越时间(mean transit time,MTT)、曲线下面积(area under the curve,AUC)、峰值减半时间(time from peak to one half,TPH)、内洗斜率(wash in slope,WIS)、达峰时间(time to peak,TTP),并将内膜的参数和肌层的参数做比值。按照病理结果纳入病例共40例,分为3组:单纯性增生(simple hyperplasia,SH)组23例,复杂性增生(complex hyperplasia,CH)组10例,非典型增生(atypical hyperplasia,AH)组7例。比较3组内膜和肌层的PI比、MTT比、AUC比、TPH比、WIS比、TTP比。结果 SH、CH、AH 3组内膜和肌层的PI比、AUC比、WIS比两两比较,差异有统计学意义(P<0.05),而MTT比、TPH比、TTP比差异无统计学意义(P>0.05)。结论子宫内膜超声造影在定量评估子宫内膜增生的不同病理分型中有一定价值。 Objective To explore the value of quantitative parameters of contrast - enhanced ultrasound (CEUS) in the evaluation of different pathological types of endometrial hyperplasia. Methods Fifty cases suspected as endometrial hyperplasia (EH) were selected from Affiliated Hospital of Nanjing University of Traditional Chinese Medicine from January to October 2016. All underwent CEUS before diagnostic curettage in order to get the time - intensity curve ( TIC ) of endometrium and myometrium, separately. Then gathered the PI, MTT, AUC, TPH, WIS,TTP of endometrium and myometrium from TICs and got the ratio of these two set of data. 40 cases were included according to pathological findings and were divided into 3 groups: simple hyperplasia (SH) group (23 cases), complex hyperplasia (CH) group(10 cases) and atypical hyperplasia (AH) group(7 cases). The PI ratio, MTT ratio, AUC ratio, TPH ratio, WIS ratio and TTP ratio of endometrium and myometrium were compared between the 3 groups. Results PI ratio, AUC ratio and WIS ratio of the 3 groups were statistically different ( P 〈 0. 05 ), while MTF ratio, TPH ratio and TFP ratio were not statistically different(P 〉 0. 05 ). Conclusion Endometrial ultrasonography is of some value in quantitative evaluation of different pathological types of endometrial hyperplasia.
作者 强也 朱正球 司海鹏 许家莹 吴林琳 蔡婷 张玫玫 QIANG Ye;ZHU Zheng -qiu;SI Hai -peng;XU Jia -ying;WU Lin -lin;CAI Ting;ZHANG Mei -mei(Department of Ultrasonography;Department of Pathology;Department of Gynecology, Affiliated Hospital of Nanjing University of TCM,Jiangsu Nanjing 210029 ,P. R. China)
出处 《中国计划生育和妇产科》 2018年第4期53-57,共5页 Chinese Journal of Family Planning & Gynecotokology
基金 江苏省中医药局科技项目(项目编号:JD201515)
关键词 超声造影 子宫内膜增生 病理分型 contrast - enhanced ultrasound endometrial hyperplasia pathological type
  • 相关文献

参考文献2

二级参考文献12

  • 1吴卫康,赵卫星.病理学[M].北京:人民卫生出版社,2008:154.
  • 2HIGHAM J M, O'BRIEN P M, SHAW R W. Assessment of menstrual blood loss using a pictorial chart [ J 1. British Journal of Obstetrics and Gynaecology, 1990, 97(8) : 734 -739.
  • 3HELLER D S, MOSQUERA C, GOLDSMITH L T, et al. Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding[J]. The Journal of Reproductive Medicine, 2011, 56 (3/4): 110 -112.
  • 4SHERMAN M E. Theories of endometrial carcinogenesis: a multidisciplinary approach [ J ]. Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Ine, 2000, 13(3) : 295 -308.
  • 5GALLOS I D, SHEHMAR M, THANGARATINAM S, et al. Oral progestogens vs levonorgestrel - releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis[ J]. American Journal of Obstetrics and Gynecology, 2010, 203 ( 6 ) : 547. el -547.10.
  • 6GALLOS I D, KRISHAN P, SHEHMAR M, et al. LNG - IUS versus oral progestogen treatment for endometrial hyperplasia: a long- term comparative cohort study [ J ]. Human Reproduction ( Oxford, England), 2013, 28 ( 11 ) : 2966 - 2971.
  • 7ORBO A, VEREIDE A, ARNES M, et al. Levonorgestrel - impregnated intrauterine device as treatment for endometrial hyperplasia: a National multicenter randomized trial [ J ]. B JOG : an International Journal of Obstetr/cs and Gynaecology, 2014 (121) : 477 -486.
  • 8E1 Behery MM, Saleh HS, Ibrahiem MA, et al. Levonorgestrel - releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia [ J ]. Reprod Sci 2015,22 (3) : 329 -334.
  • 9ABDELAZIZ A M, ABOSRIE M. Levonorgestrel - releasing intrauterine system is an efficient therapeutic modality for simp|e endometrial hyperplasia[J]. J Am Sci, 2013,9( 11 ) :417 -424.
  • 10Kong C S,Beck A H,Longacre T A,黄文斌(摘译).包括p16、ProExC或HPV原位杂交在内的一组3个标记物最适于区分原发性子宫内膜腺癌和宫颈腺癌[J].临床与实验病理学杂志,2010,26(5):517-517. 被引量:8

共引文献28

同被引文献52

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部